- Home
- IPDN vs NRSN Comparison
IPDN vs NRSN Comparison
Compare IPDN & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPDN | NRSN |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 7.6M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IPDN | NRSN |
|---|---|---|
| Price | $4.30 | $3.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $97.33 |
| AVG Volume (30 Days) | ★ 15.6M | 57.1K |
| Earning Date | 11-13-2026 | 09-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,054,219.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $0.25 |
| 52 Week High | $7.70 | $7.50 |
Technical Indicators
Market Signals| Indicator | IPDN | NRSN |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 47.33 |
| Support Level | $0.64 | $0.63 |
| Resistance Level | $7.70 | $7.50 |
| Average True Range (ATR) | 1.03 | 0.69 |
| MACD | -0.03 | -0.45 |
| Stochastic Oscillator | 29.89 | 4.39 |
Price Performance
Historical ComparisonAbout IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.